闫泽兆天欣邢影陈丹何璐璐.替吉奥联合顺铂治疗晚期胃癌临床疗效研究[J].现代生物医学进展英文版,2012,12(27):5324-5326. |
替吉奥联合顺铂治疗晚期胃癌临床疗效研究 |
Curative Effect Analysis of S-1 Combined with Cisplatin in the Treatment ofAdvanced Gastric Cancer |
|
DOI: |
中文关键词: 胃肿瘤 替吉奥 卡培他滨 顺铂 治疗结果 |
英文关键词: Stomach neoplasms S-1 Capecitabine Cisplatin Treatment outcome |
基金项目: |
|
Hits: 972 |
Download times: 931 |
中文摘要: |
目的:研究替吉奥联合顺铂治疗晚期胃癌的疗效和安全性。方法:42 例晚期胃腺癌患者随机分为观察组(21 例)与对照组(21
例)两组,观察组采用替吉奥联合顺铂,对照组采用卡培他滨联合顺铂。结果:两组患者疗效间差异无统计学意义(P>0.05)。两组的
不良反应主要为骨髓抑制、消化道反应和乏力,观察组Ⅲ~Ⅳ度血小板减少发生率显著低于对照组(P<0.05),Ⅲ ~ Ⅳ度手足综合
征的发生率亦显著低于对照组(P<0.05)。结论:替吉奥联合顺铂治疗晚期胃癌疗效与卡培他滨联合顺铂相当,但其患者耐受性更
好,值得临床进一步研究推广使用。 |
英文摘要: |
Objective: To investigate the safety and efficacy of S-1 combined with cisplatin in the treatment for patients with
advanced gastric cancer. Methods: Forty-two patients with advanced gastric cancer were randomly divided into two groups. Patients in
observation group (n=21) received S-1 and cisplatin; Patients in control group (n=21) received capecitabine and cisplatin. Results: The
efficacy of the two groups showed no statistically significant difference (P>0.05). The main untoward effects were myelosuppression,
gastroenteric reaction and weakness. Observation group showed a lower rate of untoward effects than control group. Observation group
also showed a lower rate of Ⅲ~Ⅳ thrombocytopenia (P<0.05) and hand-foot syndrome (P<0.05) than control group. Conclusions: The
treatment of the two groups were evidently effective, with observation group having better tolerance. The regimen could be clinically
recommended. |
View Full Text
View/Add Comment Download reader |
Close |